NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

Evaluate, The common stock outstanding number we have in our intro is fine. The discrepancy is in the cut-off date:
11/14/14 - 64,504,106 common outstanding does not include a) 8,052,092 approved by board to be issued Cognate on 11/12/14 but not issued as of 11/14/14 and b) 4,317,790 Woodford equity closing on 11/17/14. There is a remaining 12,694 common difference that is likely some small exercise of option or warrants between 9/30/14 and 11/14/14 that can be capture at the next 10-Q.

On the beneficial ownership section, it looks like Toucan Capital was reclassified out of its own separate line item and is now moved into the exec officers count. The increase also probably reflects the 11/12/14 issuance of RSU's.

[(Long/Sentiment) There is a small discrepancy in convertible debt number and wording that I posted on #24673, though no response yet.]